ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Case Report



METHAMPHETAMINE-INDUCED DISSEMINATED INTRAVASCULAR COAGULOPATHY: A CASE REPORT.

Obunmneme Kenechukwu Nwiyi, Sunday Onyemaechi Oriji, Ugochinyere Jane Chilaka, Chilota C Efobi, Justus Uchenna Onu, Richard Uwakwe.



Abstract
Download PDF Cited by 0 ArticlesPost

Methamphetamine abuse continues to pose a significant public health concern globally, with numerous adverse effects on various body systems. Methamphetamine is a common drug of misuse in Nigeria. It is a derivative of amphetamine, an enantiomer of ephedrine with potent addictive and majorly central nervous system (CNS) stimulating property.
We present a 30-year-old female with a history of chronic methamphetamine misuse who presented to the emergency department of Nnamdi Azikiwe University Teaching Hospital (NAUTH), Nnewi, with symptoms consistent with disseminated intravascular coagulopathy (DIC). Despite intensive inpatient management, the patient's condition rapidly deteriorated within 17days duration. This case highlights the intricate interplay between methamphetamine use and the development of DIC, emphasizing the importance of prompt recognition and appropriate management in mitigating adverse outcomes.

Key words: methamphetamine; abuse; misuse; disseminated intravascular coagulopathy; bleeding.







Bibliomed Article Statistics

36
25
22
32
41
51
17
21
29
25
24
14
R
E
A
D
S

10

19

12

27

20

150

14

20

32

14

23

24
D
O
W
N
L
O
A
D
S
010203040506070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.